458 related articles for article (PubMed ID: 23736948)
1. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
Clarkesmith DE; Pattison HM; Lane DA
Cochrane Database Syst Rev; 2013 Jun; (6):CD008600. PubMed ID: 23736948
[TBL] [Abstract][Full Text] [Related]
2. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
Clarkesmith DE; Pattison HM; Khaing PH; Lane DA
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008600. PubMed ID: 28378924
[TBL] [Abstract][Full Text] [Related]
3. Decision aids for people facing health treatment or screening decisions.
O'Connor AM; Bennett CL; Stacey D; Barry M; Col NF; Eden KB; Entwistle VA; Fiset V; Holmes-Rovner M; Khangura S; Llewellyn-Thomas H; Rovner D
Cochrane Database Syst Rev; 2009 Jul; (3):CD001431. PubMed ID: 19588325
[TBL] [Abstract][Full Text] [Related]
4. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
5. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
[TBL] [Abstract][Full Text] [Related]
6. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial.
Clarkesmith DE; Pattison HM; Lip GY; Lane DA
PLoS One; 2013; 8(9):e74037. PubMed ID: 24040156
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
8. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
[TBL] [Abstract][Full Text] [Related]
10. Self-monitoring and self-management of oral anticoagulation.
Heneghan CJ; Garcia-Alamino JM; Spencer EA; Ward AM; Perera R; Bankhead C; Alonso-Coello P; Fitzmaurice D; Mahtani KR; Onakpoya IJ
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD003839. PubMed ID: 27378324
[TBL] [Abstract][Full Text] [Related]
11. Multimedia educational interventions for consumers about prescribed and over-the-counter medications.
Ciciriello S; Johnston RV; Osborne RH; Wicks I; deKroo T; Clerehan R; O'Neill C; Buchbinder R
Cochrane Database Syst Rev; 2013 Apr; (4):CD008416. PubMed ID: 23633355
[TBL] [Abstract][Full Text] [Related]
12. Self-monitoring and self-management of oral anticoagulation.
Garcia-Alamino JM; Ward AM; Alonso-Coello P; Perera R; Bankhead C; Fitzmaurice D; Heneghan CJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD003839. PubMed ID: 20393937
[TBL] [Abstract][Full Text] [Related]
13. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
Baker WL; Cios DA; Sander SD; Coleman CI
J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
Aguilar MI; Hart R; Pearce LA
Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
[TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.
Cope S; Clemens A; Hammès F; Noack H; Jansen JP
Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559
[TBL] [Abstract][Full Text] [Related]
18. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
Vestergaard AS; Skjøth F; Larsen TB; Ehlers LH
PLoS One; 2017; 12(11):e0188482. PubMed ID: 29155884
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
Apostolakis S; Sullivan RM; Olshansky B; Lip GYH
Chest; 2013 Nov; 144(5):1555-1563. PubMed ID: 23669885
[TBL] [Abstract][Full Text] [Related]
20. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
